Ferguson Wellman Capital Management Inc. Lowers Holdings in Cigna Group $CI

Ferguson Wellman Capital Management Inc. decreased its holdings in Cigna Group (NYSE:CIFree Report) by 14.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,046 shares of the health services provider’s stock after selling 339 shares during the quarter. Ferguson Wellman Capital Management Inc.’s holdings in Cigna Group were worth $676,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in CI. Brighton Jones LLC lifted its stake in Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after acquiring an additional 318 shares during the last quarter. Waverly Advisors LLC lifted its stake in Cigna Group by 102.3% in the fourth quarter. Waverly Advisors LLC now owns 11,400 shares of the health services provider’s stock worth $3,148,000 after acquiring an additional 5,764 shares during the last quarter. Focus Partners Advisor Solutions LLC lifted its stake in Cigna Group by 15.7% in the fourth quarter. Focus Partners Advisor Solutions LLC now owns 2,940 shares of the health services provider’s stock worth $812,000 after acquiring an additional 399 shares during the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its stake in Cigna Group by 12.9% in the fourth quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 53,530 shares of the health services provider’s stock worth $14,782,000 after acquiring an additional 6,127 shares during the last quarter. Finally, Highview Capital Management LLC DE purchased a new position in Cigna Group in the fourth quarter worth approximately $287,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $293.90 on Friday. The firm’s fifty day simple moving average is $294.24 and its 200-day simple moving average is $311.67. The stock has a market capitalization of $78.45 billion, a price-to-earnings ratio of 16.04, a PEG ratio of 0.87 and a beta of 0.48. Cigna Group has a 12 month low of $256.89 and a 12 month high of $358.91. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71.

Cigna Group (NYSE:CIGet Free Report) last announced its earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. The business had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the company posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were issued a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group’s payout ratio is presently 32.97%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Royal Bank Of Canada reiterated an “outperform” rating and issued a $371.00 price target on shares of Cigna Group in a research note on Thursday, June 26th. Truist Financial set a $375.00 price objective on shares of Cigna Group in a report on Tuesday, September 2nd. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, September 13th. Wells Fargo & Company cut their price objective on shares of Cigna Group from $341.00 to $340.00 and set an “equal weight” rating on the stock in a report on Thursday, August 14th. Finally, TD Cowen raised shares of Cigna Group to a “strong-buy” rating in a report on Monday, June 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $371.81.

Check Out Our Latest Stock Report on CI

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. The trade was a 52.66% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.70% of the company’s stock.

About Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Read More

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.